Insider: Tatsis Ourania EVP, Chief Reg. & Quality Off. - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 51,239 | 0 | 51,239 |
| Value | $19,566,636.93 | $0.00 | $19,566,636.93 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/10/2025 | DDS | 3,242 | Direct | COM | $499.99 | $1,620,967.58 | 51,239 |
| 03/04/2025 | DDS | 4,058 | Direct | COM | $485.49 | $1,970,118.42 | 54,481 |
| 02/25/2025 | DDS | 354 | Direct | COM | $480.95 | $170,256.30 | 64,031 |
| 02/18/2025 | DDS | 244 | Direct | COM | $455.06 | $111,034.64 | 67,695 |
| 02/11/2025 | DDS | 310 | Direct | COM | $459.83 | $142,547.30 | 64,021 |
| 06/03/2024 | DDS | 2,175 | Direct | COM | $460.00 | $1,000,500.00 | 49,098 |
| 05/31/2024 | DDS | 2,250 | Direct | COM | $445.00 | $1,001,250.00 | 51,273 |
| 05/30/2024 | DDS | 2,350 | Direct | COM | $439.11 | $1,031,908.50 | 53,523 |
| 02/26/2024 | DDS | 354 | Direct | COM | $425.70 | $150,697.80 | 55,804 |
| 02/21/2024 | DDS | 360 | Direct | COM | $421.77 | $151,837.20 | 59,467 |
| 02/20/2024 | DDS | 480 | Direct | COM | $420.79 | $201,979.20 | 59,827 |
| 02/12/2024 | DDS | 314 | Direct | COM | $420.24 | $131,955.36 | 68,179 |
| 08/23/2023 | DDS | 2,500 | Direct | COM | $355.00 | $887,500.00 | 48,637 |
| 08/10/2023 | DDS | 5,750 | Direct | COM | $345.79 | $1,988,292.50 | 51,137 |
| 02/27/2023 | DDS | 283 | Direct | COM | $287.20 | $81,277.60 | 56,876 |
| 02/27/2023 | DDS | 51 | Direct | COM | $288.33 | $14,704.83 | 56,825 |
| 02/27/2023 | DDS | 20 | Direct | COM | $289.29 | $5,785.80 | 56,805 |
| 02/21/2023 | DDS | 4 | Direct | COM | $291.01 | $1,164.04 | 60,943 |
| 02/21/2023 | DDS | 145 | Direct | COM | $292.85 | $42,463.25 | 60,798 |
| 02/21/2023 | DDS | 124 | Direct | COM | $294.77 | $36,551.48 | 60,467 |
| 02/21/2023 | DDS | 207 | Direct | COM | $293.83 | $60,822.81 | 60,591 |
| 02/14/2023 | DDS | 71 | Direct | COM | $295.89 | $21,008.19 | 65,694 |
| 02/14/2023 | DDS | 20 | Direct | COM | $296.48 | $5,929.60 | 65,674 |
| 02/14/2023 | DDS | 43 | Direct | COM | $297.98 | $12,813.14 | 65,631 |
| 02/14/2023 | DDS | 51 | Direct | COM | $300.58 | $15,329.58 | 65,445 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research